Evidence map›Paper›PMID 20167197›Full record

ArticleVeterinary research

Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro.

Kerry McLaughlin, Julian Seago, Lucy Robinson, Charles Kelly, Bryan Charleston

Open access · bronzeAbstract read
In one paragraph

Article in Veterinary research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Recent insights into HSP70: proteostasis and beyond.Frontiers in molecular biosciences · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kerry McLaughlinInstitute for Animal Health, Pirbright, Woking, Surrey GU24 0NF, United Kingdom.
Julian Seago
Lucy Robinson
Charles Kelly
Bryan Charleston
The Pirbright Institute · GBGuy's Hospital · GBOrganic Research Centre · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00001432
6 · The paper itself

Abstract

Foot-and-mouth disease virus (FMDV) is the causative agent of a highly contagious acute vesicular disease affecting cloven-hoofed animals, including cattle, sheep and pigs. The current vaccine induces a rapid humoral response, but the duration of the protective antibody response is variable, possibly associated with a variable specific CD4+ T cell response. We investigated the use of heat shock protein 70 (Hsp70) as a molecular chaperone to target viral antigen to the Major Histocompatibility Complex (MHC) class II pathway of antigen presenting cells and generate enhanced MHC II-restricted CD4+ T cell responses in cattle. Monocytes and CD4+ T cells from FMDV vaccinated cattle were stimulated in vitro with complexes of Hsp70 and FMDV peptide, or peptide alone. Hsp70 was found to consistently improve the presentation of a 25-mer FMDV peptide to CD4+ T cells, as measured by T cell proliferation. Complex formation was required for the enhanced effects and Hsp70 alone did not stimulate proliferation. This study provides further evidence that Hsp70:peptide complexes can enhance antigen-specific CD4+ T cell responses in vitro for an important pathogen of livestock.

Indexed as

AnimalsAntigens, ViralCattleCattle DiseasesCD4-Positive T-LymphocytesCells, CulturedFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusHSP70 Heat-Shock ProteinsViral VaccinesAntigens, ViralHSP70 Heat-Shock ProteinsViral Vaccines

Identifiers

PMID20167197
PMCPMC2831533
OpenAlexW2156640555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.